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OBJECTIVE—To examine fat biopsy samples from lean insulin-
sensitive and obese insulin-resistant nondiabetic individuals for
evidence of endoplasmic reticulum (ER) stress.
RESEARCH DESIGN AND METHODS—Subcutaneous fat bi-
opsies were obtained from the upper thighs of six lean and six
obese nondiabetic subjects. Fat homogenates were used for
proteomic (two-dimensional gel and MALDI-TOF/TOF), Western
blot, and RT-PCR analysis.
RESULTS—Proteomic analysis revealed 19 differentially up-
regulated proteins in fat of obese subjects. Three of these
proteins were the ER stress–related unfolded protein response
(UPR) proteins calreticulin, protein disulﬁde-isomerase A3, and
glutathione-S-transferase P. Western blotting revealed upregula-
tion of several other UPR stress–related proteins, including
calnexin, a membrane-bound chaperone, and phospho c-jun
NH2-terminal kinase (JNK)-1, a downstream effector protein of
ER stress. RT-PCR analysis revealed upregulation of the spliced
form of X-box binding protein-1s, a potent transcription factor
and part of the proximal ER stress sensor inositol-requiring
enzyme-1 pathway.
CONCLUSIONS—These ﬁndings represent the ﬁrst demonstra-
tion of UPR activation in subcutaneous adipose tissue of obese
human subjects. As JNK can inhibit insulin action and activate
proinﬂammatory pathways, ER stress activation of JNK may be a
link between obesity, insulin resistance, and inﬂammation.
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O
besity is associated with insulin resistance and
with a low-grade state of inﬂammation (1).
Whereas the cause of neither is completely un-
derstood, there is good evidence to show that
free fatty acids (FFAs) play an important role in the devel-
opment of obesity-related insulin resistance and inﬂamma-
tion (2). Plasma FFA levels are increased in most obese
people (3). Acutely raising plasma FFA levels increases
insulin resistance (4), whereas lowering plasma FFA levels
reduces insulin resistance (5). Mechanisms involved in FFA-
induced insulin resistance include accumulation (in muscle
and liver) of lipids and lipid intermediates, including diacyl-
glycerol; activation of several protein kinase C isoforms; and
reduction in tyrosine phosphorylation of insulin receptor
substrate-1/2 (6–8). FFAs also activate the proinﬂammatory
nuclear factor B pathway (6,9), in part, via signaling through
toll-like receptor-4 pathways (10). However, not all obese,
insulin-resistant subjects have elevated plasma FFA levels. It
is therefore likely that there are other causes for obesity-
related insulin resistance. One of these appears to be endo-
plasmic reticulum (ER) stress. Indeed, chronic excessive
nutrient intake has been shown to cause ER stress in adipose
tissue of ob/ob mice and mice fed high-fat diets (11–13).
The ER is a major site for protein as well as for lipid and
sterol synthesis (14,15). Ribosomes attached to the ER
membranes release newly synthesized peptides into the
ER lumen, where protein chaperones and foldases assist
in the proper posttranslational modiﬁcation and folding of
these peptides (14–16). The properly folded proteins are
then released to the Golgi complex for ﬁnal modiﬁcation
before they are transported to their ﬁnal destination. If the
inﬂux of misfolded or unfolded peptides exceeds the ER
folding and/or processing capacity, ER stress ensues.
Three proximal ER stress sensors have been identiﬁed.
They are inositol-requiring enzyme (IRE)-1, PKR-like ER
protein kinase (PERK), and activating transcription fac-
tor-6. These sensors trigger activation of pathways, termed
the unfolded protein response (UPR), which act to allevi-
ate ER stress. The UPR can achieve this by slowing protein
synthesis and/or by turning up the production of protein
chaperones needed for proper protein folding or, if unsuc-
cessful, by degrading the unfolded proteins (14,16). So far,
however, ER stress has only been reported in some rodent
models of obesity (11–13) but not in fat of obese human
subjects. We have therefore examined fat biopsy samples
from lean and obese nondiabetic individuals for evidence
of ER stress using proteomic, Western blot, and RT-PCR
analyses.
RESEARCH DESIGN AND METHODS
Six lean and six obese healthy volunteers were studied. Their clinical
characteristics are shown in Table 1. None of the participants had a family
history of diabetes or other endocrine disorders or were taking medications.
Their body weights were stable for at least 2 months before the biopsies.
Compared with the nonobese volunteers, the obese volunteers were heavier
(93.4 vs. 77.4 kg; P  0.03) and had more body fat (40.7 vs. 19.9 kg; P  0.004)
but had the same fat-free mass (57.6 vs. 57.6 kg) and were insulin resistant
(1/homeostasis model assessment 0.44 vs. 0.29; P  0.05). Informed written
consent was obtained from all subjects after explanation of the nature,
purpose, and potential risks of these studies. The study protocol was
approved by the institutional review board of Temple University Hospital.
Fat biopsies. The subjects were admitted to the Temple University Hospital
Clinical Research Center on the day before the studies. At 8:00 A.M.o nt h e
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2438 DIABETES, VOL. 57, SEPTEMBER 2008day after admission, a venous blood sample was obtained and an open fat
biopsy was performed by a surgeon. Fat biopsies were obtained from the
lateral aspect of the upper thigh (15 cm above the patella) under local
anesthesia, as described (4). The excised fat was dropped immediately into
isopentane and kept at its freezing point (160°C) by liquid nitrogen. The
frozen fat was stored at 80°C until analyzed.
Sample preparation for two-dimensional gel analysis. Frozen adipose
tissue from six nonobese and six obese nondiabetic volunteers was individ-
ually processed by grinding with a mortar and pestle cooled with liquid
nitrogen. Frozen powders from each individual tissue block were thawed by
adding 0.8 ml of cold lysis buffer (7 mol/l urea, 2 mol/l thiourea, 4% CHAPS, 40
mmol/l Tris, and 60 mmol/l DTT) and sonicated in an ice bath for 1 min
(Sonic Dismembrator; Fisher Scientiﬁc). Sonicated solutions were centrifuged
at 10,000g for 12 min at 4°C. Supernatants were collected and acetone added
to precipitate proteins. Precipitated proteins were resolubilized using the
above lysis buffer. Protein concentrations in the extracts were measured in
triplicate using a Bio-Rad Bradford-based protein assay with BSA as the
standard.
Two-dimensional gel electrophoresis. Adipose tissue lysates were pro-
cessed individually (six from each group of subjects). For the ﬁrst-dimension
separation, 50 g of sample protein was diluted in 125 l of rehydration buffer
and loaded onto an immobilized pH gradient (IPG) strip by overnight passive
in-gel rehydration. A global view of the proteome was obtained initially using
IPG strips of pI 3–10 (data not shown). To enhance resolution and sensitivity,
narrow-range IPG strips (pI 4–7 and 6–10) were subsequently used. The
rehydration buffer contained 8 mol/l urea, 2% CHAPS, 0.2% carrier ampholytes,
and 10 mmol/l DTT for pI 4–7 linear and pI 3–10 nonlinear IPG strips. The pI
6–10 IPG strips were rehydrated with the rehydration buffer containing 15
mg/ml Destreak reagent substitute for 10 mmol/l DTT. Isoelectric focusing
within the strips was performed at 20°C with a Ettan IPGphor system
Amersham (Piscataway, NJ) using a total of 12,000 V/h with a maximum of
8,000 V.
For two-dimensional separation, the IPG strips were soaked for 15 min in
10 ml of equilibration buffer (6 mol/l urea, 30% glycerol, 2% SDS, 1% DTT, and
0.05 mol/l Tris, pH 8.8) followed by 15 min in 10 ml of a second equilibration
buffer (with 2.5% iodoacetamide substituted for 1% DTT) and positioned
against 10–14% SDS polyacrylamide gels in a Bio-Rad Mini-PROTEAN 3
System at 200 V for 45 min. Polyacrylamide gels were then ﬁxed twice using
50% methanol, 7% acetic acid, and balance water. The resolved protein spots
in the gels were visualized with Sypro-Ruby ﬂuorescence total protein stain.
Image analysis of two-dimensional gels. Fluorescence images of individual
gels from the 12 adipose tissue lysates were captured with a FLA-5000 Fluor
Imager (Fuji Photo Film, Tokyo, Japan) and analyzed using PDQuest software
(version 8.0). After automatic detection of spots by PDQuest software, the
ﬁles were also inspected manually to assess accuracy of computer-generated
images. The software calculated individual spot “volumes” in each gel by
density/area integration. To control for slight differences in protein loading
across gels, the spot volume obtained from each individual fat lysate was
automatically calculated by image analysis software and normalized to total
spot volume on that gel.
In-gel trypsin digestion. Differentially expressed spots were excised using
an Xcise automated robotic system (Shimadzu Biotech, Columbia, MD).
Destaining of excised gel pieces was performed by two 30-min washes with
50% acetonitrile containing 50 mmol/l ammonium bicarbonate. Following
dehydration with 100% acetonitrile, 10 l of 12.5 ng/l sequencing grade
trypsin (Promega, Madison, WI) was added to the gel pieces and incubated
overnight at 37°C. Resulting tryptic peptides were extracted twice with 15 l
(5% formic acid, 50% acetonitrile, and balance water) for 20 min, and the
pooled extracts were desalted with ZipTips C18 (Millipore, Billerica, MA).
MALDI-TOF/TOF analysis. The desalted peptides from each spot were
mixed 1:1 with matrix solution (1% -cyano-4-hydroxy cinnamic acid in 50%
acetonitrile and 50% 0.1% triﬂuoroacetic acid), and 1.0-l volumes were
applied to wells of an AnchorChip sample target plate used for the Bruker
Auto-ﬂex MALDI-TOF/TOF instrument. Peptide mass ﬁngerprints were ob-
tained using the reﬂective and positive ion mode. Mass spectra were collected
from the sum of 100–400 laser shots, and monoisotopic peaks were generated
by FlexAnalysis software with signal-to-noise ratio of two to one. Mass peak
value calculations used two trypsin autodigestion peptides with M  H values
842.509 and 2211.104 as internal standards. Proteins were identiﬁed by
matching the calibrated peptide mass values within Swiss-Prot protein data-
base for homosapiens using an in-house version of Mascot Server 2.1
imbedded in Bruker’s Biotool software. Match variances allowed were a mass
tolerance of 50 ppm, one missed trypsin cleavage, ﬁxed modiﬁcation of
carbamidomethyl cysteine, and variable modiﬁcation of methionine oxidation.
For the samples that did not produce a “hit” with a conﬁdent score, peptide
peaks with good signal were further fragmented using laser-induced decom-
position to obtain LIFT-TOF/TOF spectra, and these tandem mass spectra data
alone or combined with the previously produced mass spectra data were used
to search against the protein database through the Mascot.
Western blot analysis. Proteins (30–80 g) from the same adipose tissue
lysates as used for the two-dimensional gels were separated by 10–14%
gradient SDS-PAGE. The separated proteins were transferred to a nitrocellu-
lose membrane in a semidry blotting chamber according to the manufacturer’s
protocol (Bio-Rad, Hercules, CA).
Blots were blocked with 5% milk in Tris-buffered saline solution (pH 7.6)
containing 0.05% Tween-20 and probed with the following rabbit anti-human
antibodies from Santa Cruz Biotechnology (Santa Cruz, CA) at a concentration
of 0.4 g/ml: protein disulﬁde isomerase A3 (PDI) (SC-20132), calreticulin
(CRT) (SC-11398), and calnexin (CNX) (SC-11397). In addition, a rabbit
antiserum that detects phospho c-jun NH2-terminal kinase (JNK)-1, -2, and -3
(Cell Signaling Technology, Danvers, MA) and a rabbit antiserum that detects
total JNK were used. Blots were incubated with primary antibody overnight at
4°C with gentle shaking and then incubated with a mouse anti-rabbit horse-
radish peroxidase–conjugated secondary antibody (1:10,000) (Biomeda, Fos-
ter City, CA) for1ha troom temperature. Blots were exposed using a
chemiluminescent detection method (Enhanced ECL Detection System; GE
Healthcare BioSciences, Piscataway, NJ).
RT-PCR. Total RNAs were isolated from frozen adipose tissues, and real-time
RT-PCR was performed with a SYBR Green One-Step qRT-PCR kit (Invitrogen,
Carlsbad, CA) and a Light-Cycler (Roche, Indianapolis, IN). Primers for X-box
binding protein (XBP)-1s (NM-005080) were sense TTGAGAACCAGGAGT
TAAG and antisense CTGCACCTGCTGCGGACT.
Statistical analysis. Two-dimensional gel analysis was performed by
PDQuest software (Bio-Rad), version 8.0. Each gel from obese and lean fat
samples was enumerated and analyzed for spot detection, background sub-
traction, and protein spot volume quantiﬁcation. Of six samples per group, the
gel image showing the highest quality of spots and the best protein pattern
was chosen as a reference template, and spots in a reference gel were then
matched across all gels. Manual corrections were performed to validate the
matches automatically generated by the software. Spot volume values were
normalized in each gel by dividing the raw quantity of each spot by the total
volume of all the spots included in the same gel. For each protein spot, the
average spot volume values and its SD in each group were determined. The
match spots were subjected to Student’s t test in order to determine the spots
that were differentially expressed. Only those spots that show a statistically
signiﬁcant difference with a conﬁdence level of 0.05 were chosen for identi-
ﬁcation. To test for intergel reproducibility, two-dimensional gel analysis was
performed in triplicate using one representative sample. Equal amounts of
high-quality protein spots (345 for pI 4–7) were detected. The average
variance (coefﬁcient of variation) of the normalized spot volume was deter-
mined to be 19.25%.
RESULTS
Proteomic analysis. Gels with isoelectric focusing
ranges of PI 4–7 and 6–10 produced a total of 900
protein spots in each gel (Fig. 1). The comparison of all
spots visualized yielded 24 spots that were signiﬁcantly
different in lean versus obese volunteers. Three of these
spots represented multiple isoforms of vimentin. Three
TABLE 1
Study subjects
Lean Obese P
Sex (male/female) 4/2 3/3
Age (years) 36 	 44 4 	 4N S
Weight (kg) 77.4 	 3.4 93.4 	 5.6 0.03
Height (cm) 180.0 	 2.7 167 	 4.5 0.03
BMI (kg/m
2) 24.0 	 1.2 33.5 	 1.6 0.02
Fat (kg) 19.9 	 2.9 40.7 	 5.9 0.004
Fat-free mass (kg) 57.6 	 3.5 57.6 	 5.7 NS
1/homeostasis
model assessment
0.441 	 0.126 0.291 	 0.02 0.05
Fasting blood
glucose (mg/dl) 97.1 	 2.4 93.5 	 1.2 NS
FFA (mol/l) 481 	 81 424 	 37 NS
Data are means 	 SD.
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2  22). Two other spots could not be identiﬁed (22  2 
20). Of 20 remaining differentially expressed proteins, 19
were upregulated and 1 (-enolase) was downregulated in
obese versus lean volunteers (Table 2). The differentially
expressed proteins were grouped into the following cate-
gories: 1) UPR and stress (seven proteins), 2) energy and
FFA metabolism (ﬁve proteins), 3) structural proteins
(four proteins), and 4) protein transport and signaling
(four proteins) (Table 2).
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FIG. 1. Expression levels of the UPR proteins CRT and PDI in adipose tissue of one lean and one obese subject (upper panels). Differentially
expressed proteins in fat homogenates from one lean and one obese subject. Proteins were separated by isoelectric focusing and molecular weight
(2-DG) as described in RESEARCH DESIGN AND METHODS. The subproteom from each sample was assessed using Pi ranges of 4–7 (middle panels) and
6–10 (lower panels). The proteins were stained with spyro-ruby and images compared by PD Quest software. The numbers correspond to the spot
numbers in Table 2. The arrows indicate upregulated proteins in the fat of obese subjects.
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proteins were overexpressed in two-dimensional gels in
adipose tissue from obese volunteers: CRT, a protein chap-
erone, increased from undetectable to 1,019 	 236 arbitrary
units; PDI, a protein foldase, increased approximately three-
fold; and glutathione-S-transferase P, an antioxidant protein
belonging to a UPR-regulated pathway, increased 1.8-fold
(Fig. 1; Table 2).
Several cytosolic small heat shock proteins (HSPs) (20 and
27 kDa HSP) and one mitochondrial HSP (60 kDa HSP) were
also overexpressed in the adipose tissue of obese volunteers,
suggesting the presence of cytosolic and mitochondrial
stress in addition to ER stress (Table 2).
Other proteins. Several proteins involved in energy and
FFA metabolism (ATP synthase subunit-
, perilipin, alde-
hyde dehydrogenase, -enolase, and carbonic anhydrase-1),
structural proteins (myosin light-chain polypeptide-6, tropo-
myosin 
-chain, tropomyosin 4-chain, and vimentin), and
proteins involved in transport and signaling (-synuclein,
-guanosine 5
-diphosphate dissociation inhibitor-1, 14-3-3
protein-, and galectin-1) were also differentially overex-
pressed in fat from obese volunteers (Table 2).
Western blot analysis. Western blotting conﬁrmed up-
regulation of CRT and PDI and revealed upregulation of
CNX (1.8-fold), a membrane bound chaperone and
phospho-JNK-1 2.0-fold, a downstream effector pro-
tein of the UPR. Phospho-JNK 2/3, however was un-
changed (Fig. 2).
RT-PCR analysis. Upregulation of the spliced form of
XBP-1s, a part of the IRE-1/XBP-1 proximal ER stress
sensor, and of tumor necrosis factor-, a proinﬂammatory
cytokine, were documented with RT-PCR, whereas there
were no differences in interleukin-1
 and -6 mRNA in
adipose tissue of lean and obese subjects (Fig. 3).
DISCUSSION
In the present study, we found activation of one of three UPR
proteins, known to be proximal ER stress sensors (IRE-1/
XBP-1), but failed to detect statistically signiﬁcant activation
of the other two ER stress sensors (activating transcription
factor-6 and PKR-like ER protein kinase) and two other UPR
proteins (glucagon-like peptide-78 and C/EBP homologous
protein) in fat from obese subjects (data not shown). This
TABLE 2
Proteins differentially expressed in two-dimensional gels
Spot no.
Protein
identiﬁcation
Swiss protein
accession no.
Mouse
score
Peptides
matched
Normalized spot
volumes 	 SD
(lean; n  6)
Normalized spot
volumes 	 SD
(obese; n  6) P
UPR and stress
3 CRT P27797 66 7 0 1,019 	 236 0.001
23 PDI P30101 61 6 421 	 328 1,170 	 63 0.01
20 20 kDa HSP
-6 014558 76 5 2,534 	 1,157 7,530 	 248 0.001
21 27 kDa HSP
-1 P04792 78 8 4,242 	 1,438 8,140 	 1643 0.001
25 HSP
-5 P02511 74 9 4,162 	 558 8,967 	 2,918 0.049
16 60 kDA HSP P10809 69 6 600 	 558 1,868 	 56 0.001
19 Glutathione-S-
transferase P
P09211 107 8 2,231 	 698 3,936 	 390 0.013
Energy and FFA
metabolism
12 ATP synthase
subunit-

P06576 138 11 2,413 	 801 5,499 	 1,251 0.01
15 Perilipin 060240 57 6 1,602 	 381 3,960 	 1,019 0.007
22 Aldehyde
dehydrogenase
P05091 87 9 1,341 	 161 4,088 	 799 0.001
24 -Enolase P06733 65 7 803 	 214 293 	 74 0.018
26 Carbonic
anhydrase-1
P00915 108 11 2,463 	 774 4,846 	 523 0.012
Structural
proteins
1 Myosin
light-chain
polypeptide-6
P60660 60 6 1,792 	 528 3,837 	 284 0.002
2 Tropomyosin

-chain
P07951 58 6 1,141 	 443 4,072 	 531 0.03
4 Tropomyosin
4-chain
P67936 94 8 770 	 355 3,429 	 779 0.002
7–9 Vimentin P08670 204 19 3,136 	 1,418 11,005 	 3,353 0.007
Protein transport
and signaling
6 -Synuclein 076070 66 4 488 	 465 1,714 	 670 0.034
11 GDP
dissociation
inhibitor-1
P52565 75 5 2163 	 612 3,168 	 286 0.049
5 14-3-3 protein- P61981 78 6 875 	 525 3,619 	 1,005 0.005
10 Galectin-1 P09382 113 10 9,030 	 1,387 25,049 	 4,175 0.001
Data are means 	 SD.
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severe and long-lasting ER stress activates all three UPR
pathways simultaneously, whereas different duration and
types of ER stress can activate one, two, or all three
pathways in different tissues (17).
The IRE-1/XBP-1 pathway regulates induction of chaper-
one synthesis. IRE-1 activation results in dimerization and
autophosphorylation of IRE-1. This activates IRE-1’s endonu-
clease activity and initiates splicing of a 26-bp segment from
the XBP-1 mRNA, creating XBP-1s, a potent transcription
factor that targets genes encoding ER chaperones, including
CRT, CNX, and PDI, a foldase that catalyzed disulﬁde bond
formation (14,17,18). XBP-1s mRNA, CRT, CNX, and PDI
were all upregulated in fat of obese compared with nonobese
volunteers (Figs. 1–3), indicating activation of UPR and
suggesting presence of ER stress. The lectin/chaperones
CNX and CRT facilitate protein folding by shielding unfolded
protein regions from surrounding proteins, thus preventing
aggregation. In addition, the CNX/CRT cycle is one arm of the
quality-control machinery in the ER that monitors the glyco-
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FIG. 2. Protein abundance (by Western blots) of CNX/-actin,
CRT/-actin, PDI, phospho–JNK-1/JNK-1 and phospho–JNK-2,3/
JNK-2,3 in subcutaneous adipose tissue from four lean (insufﬁcient
fat was available for Western analysis from two of six lean subjects)
and six obese nondiabetic subjects. Inserts show representative
Western blots.
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cule is exported to the Golgi complex or targeted for ER-
associated degradation (14,19).
In addition, we found phospho–JNK-1 (but not phospho–
JNK-2 or phospho–JNK-3) to be markedly upregulated. ER
stress has previously been reported to activate JNK to
phospho-JNK (primarily to phospho–JNK-1) in cultured
cells and animal models (11,20–22). JNK activation is
coupled to ER stress–induced IRE-1 activation through
recruitment of tumor necrosis factor receptor–associated
factor-2 and apotosis signal–regulating kinase-1 to the
cytosolic leaﬂet of the ER membrane (22). The complex of
these three proteins phosphorylates and activates JNK.
JNK activation has been shown to produce insulin resis-
tance and inﬂammation, while JNK inhibition improved
insulin sensitivity in fat, liver, and muscle of several animal
models of obesity (11).
Proteosome analysis also revealed a 3.5-fold increase in
-synuclein. -Synuclein belongs to a family of small un-
folded proteins with unknown physiological functions.
-Synuclein has been detected in various cancers, particu-
larly in advanced stages of breast and ovarian cancer (23). In
vitro, -synuclein inhibits normal metastatic checkpoint con-
trol, promotes cancer invasion and metastasis, and is being
used as a marker for assessing breast cancer progression
(24). The observed large upregulation of -synuclein in fat
from obese individuals is interesting in view of the recog-
nized increase in cancer risk in obesity (25,26).
Pertubation of ER function was not restricted to the ER
but involved other sections of the protein secretory path-
way, as indicated by upregulation of several cytosolic
protein chaperones including three small HSPs (20 kDa
HSP
-6, 27 kDa HSP
-1, and HSP
-5). In addition, it
involved mitochondria, as evidenced by upregulation of
the mitochondrial 60-kDa HSP (chaperonin), which partic-
ipates in the folding of newly synthesized proteins that are
transported from the cytosol to mitochrondria (14).
White adipose tissue hypoxia associated with in-
creased expression of ER stress markers has been re-
ported in mice (27,28). To explore a possible role of
adipose tissue hypoxia in the observed UPR, we have
determined expression of hemoxygenase-1 (hemox-1).
This gene has been shown to be dramatically upregulated
in fat of hypoxic ob/ob mice (28). There was, however, no
difference in the hemoxygenase-1 mRNA/18 small-subunit
ribosomal RNA ratios in subcutaneous fat from lean and
obese subjects (0.5 vs. 0.5; P  NS).
It has been shown, in vitro and in animal models, that
nutrient excess (the cause for obesity) produces ER stress
(11,12), and it has been speculated that the reason for ER
stress in response to nutrient excess may be increased
demand for lipid and protein synthesis and for structural
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FIG. 3. Messenger RNA (mRNA) corrected for 18s ribosomal RNA (18sr RNA) of sXBP-1, tumor necrosis factor-, interleukin-1, and
interleukin-6 in six lean and six obese nondiabetic subjects.
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and storing excess nutrients (i.e., the adipose tissue and
the liver) (12). Compatible with this interpretation, we
found overexpression of several structural proteins and
proteins related to energy and fat metabolism and protein
transport. Moreover, an increase in reactive oxygen spe-
cies (ROS), which frequently accompanies nutrient ex-
cess, can cause ER stress (29) and activate the UPR (30).
ER stress has been demonstrated to trigger activation of
several serine/threonine kinases, including JNK and IB
kinase and is a major source for the production of ROS,
which not only produces insulin resistance but also stim-
ulates synthesis and release of proinﬂammatory cytokines
and chemokines such as tumor necrosis factor-, interleu-
kin-1
, interleukin-6, and monocyte chemotactic protein-1
(11 and this article). Thus, the ER might be a proximal site
that senses nutritional excess and translates that excess
into metabolic and inﬂammatory responses (12). Finally,
all our fat biopsies were from thigh subcutaneous adipose
tissue, and, thus, the results may not be representative of
fat in other locations.
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